Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

Hepatology

Volumn 27, Issue 3, 1998, Pages 868-872

  Mathurin, Philippe ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIREMIA;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ALCOHOL DRINKING; FEMALE; HEPATITIS C; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 0031952915     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270333     Document Type: Article

References (22)

1. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-832.
2. Alter MJ, Marcolis HS, Krawczyski K, Judson FN, Mares A, Alexander WJ, Hu PY, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-1905.
3. Poynard T, Bedossa P, Metavir and Clinivir Cooperative Study Groups. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. J Viral Hepat 1997;4:199-208.
4. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. HEPATOLOGY 1995;21:285-290.
5. Stanley AJ, Haydon GH, Piris J, Jams LM, Hayes PC. Assessment of liver histology in patients with normal transaminase levels. Eur J Gastroenterol Hepatol 1996;8:869-872.
6. Alberti A, Morsica G, Chemello L, Cavalletto D, Noventa F, Pontisso P, Ruol A. Hepatitis viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992;340:397-398.
7. Yuki N, Hayashi N, Takehara T, Hagiwara H, Hiramatsu N, Naito M, Kawanishi Y, et al. Serum hepatitis C virus RNA levels and liver injury in volunteer blood donors. Am J Gastroenterol 1994;89:1462-1466.
8. Brillanti S, Folli M, Gaiani S, Masci C, Migloli M, Barbara L. Persistent hepatitis C viraemia without liver disease. Lancet 1993;341:464-465.
9. Prieto M, Olaso V, Verdu C, Cordoba J, Gisbert C, Rayon M, Carrasco D, et al. Does the healthy hepatitis C virus carrier state really exist? an analysis using polymerase chain reaction. HEPATOLOGY 1995;22:413-417.
10. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993;88:240-243.
11. Kodama T, Tamamki T, Katabami S, Katamuma A, Yamashita H, Azuma N, Kamijo K, et al. Histological findings in asymptomatic hepatitis C virus carriers. J Gastroenterol Hepatol 1993;8:403-405.
12. Shindo M, Aral K, Sokawa Y, Okuno T. The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values. HEPATOLOGY 1995;22:418-425.
13. Bruno S, Rossi S, Petroni ML, Villa E, Zuin M, Polda M. Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus. BMJ 1994;308:697.
14. Marcellin P, Gournay J, Cymes K, Martinet M, Benhamou JP, Degott C, Erlinger S. Liver histology in asymptomatic anti-HCV patients with normal ALT levels. HEPATOLOGY 1994;20:255A.
15. The METAVIR Cooperative Group. Inter and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C. HEPATOLOGY 1994;20:15-20.
16. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, et al. A comparison of three Interferon alpha-2b regimens for long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995;332:1457-1462.
17. Bedossa P, Poynard T, for the METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. HEPATOLOGY 1996;24:289-293.
18. Morisco F, Del Vecchio-Blanco G, Tucillo C, Iasevoli P, Sessa G, Caporaso N. Levels of HCV RNA in subjects with and without HCV-related chronic liver disease [Abstract]. J Hepatol 1995;23(Suppl):A25.
19. Payen JL, Izopet J. Le statut de porteur sain du virus de l'hépatite C existe t-il? Gastroenterol Clin Biol 1996;20:531-534.
20. Naito M, Hayashi N, Hagiwara H, Hiramatsu N, Kasahara A, Fusamoto H, Kamada T. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. HEPATOLOGY 1994;19:871-875.
21. Hagiwara H, Hayashi N, Mita E, Naito M, Kashara A, Fusamoto H, Kamada T. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. HEPATOLOGY 1993;17:545-550.
22. Serfaty L, Chazouillères O, Pawlotsky JM, Andréani T, Pellet C, Poupon R. Level of viremia, genotype, histological features and effect of interferon (IFN) therapy in hepatitis C virus (HCV) carriers with persistently normal ALT activity. HEPATOLOGY 1994;20:165A.